SEARCH
Enter your search term below:
INSIGHTS / News
University spin-out “Azellon” announces recruitment phase of knee repair clinical trial
Azellon Ltd, (“Azellon”), a spin-out from the University of Bristol and the developer of stem cell therapies for tissue repair, today announced that recruitment had commenced for the phase I/IIa trial of its Cell Bandage for knee meniscus repair.
Built upon the pioneering work of Professor Anthony Hollander from the University’s School of Cellular and Molecular Medicine, the Azellon procedure takes stem cells, harvested from the patient’s own bone marrow, grows them on a structural bio-scaffold, and two weeks later implants the newly created Cell Bandage into the patient’s knee.
Read the full story on the University website
Mailing List sign-up
Get all the fresh insights first! Stay up-to-date with all the
latest investment news, blogs and all things SETsquared.
Close 
Mailing List sign-up
LATEST
TWEETS
Europe's biggest #startup & #tech event @VivaTech returns between 16 and 19 June 2021! Meet attendees from 125 cou… twitter.com/i/web/status/14026…
@csctbath Summer Showcase confirmed speakers:
- Prof Sir Richard Catlow @cardiffuni @ucl
- Prof Mercedes Maroto-Va… twitter.com/i/web/status/14025…Thank you to everyone that joined us this morning and to our panel! We hope we've inspired people to think more ab… twitter.com/i/web/status/14025…
Here are some #sustainable changes businesses have made in the last 12 months:
travelling less
trying to become… twitter.com/i/web/status/14025…"We're seeing regulators, investors and customers wanting and pushing companies to be more sustainable. It is being… twitter.com/i/web/status/14025…
